These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 23507054)

  • 1. Infections in vasculitis.
    Guillevin L
    Best Pract Res Clin Rheumatol; 2013 Feb; 27(1):19-31. PubMed ID: 23507054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Twenty-seven years' activities of the French vasculitis study group (FVSG)].
    Guillevin L
    Rev Med Interne; 2007 Dec; 28 Suppl 4():S263-5. PubMed ID: 18029060
    [No Abstract]   [Full Text] [Related]  

  • 3. Vasculitis related to viral and other microbial agents.
    Teng GG; Chatham WW
    Best Pract Res Clin Rheumatol; 2015 Apr; 29(2):226-43. PubMed ID: 26362741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virus-induced vasculitis.
    Sharlala H; Adebajo A
    Curr Rheumatol Rep; 2008 Dec; 10(6):449-52. PubMed ID: 19007534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of hepatitis C-associated mixed cryoglobulinemia vasculitis.
    Saadoun D; Delluc A; Piette JC; Cacoub P
    Curr Opin Rheumatol; 2008 Jan; 20(1):23-8. PubMed ID: 18281853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic strategies for systemic necrotizing vasculitides.
    Guillevin L; Pagnoux C
    Allergol Int; 2007 Jun; 56(2):105-11. PubMed ID: 17460440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. When should immunosuppressants be prescribed to treat systemic vasculitides?
    Guillevin L; Pagnoux C
    Intern Med; 2003 Apr; 42(4):313-7. PubMed ID: 12729318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restoration of peripheral immune homeostasis after rituximab in mixed cryoglobulinemia vasculitis.
    Saadoun D; Rosenzwajg M; Landau D; Piette JC; Klatzmann D; Cacoub P
    Blood; 2008 Jun; 111(11):5334-41. PubMed ID: 18292291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current possibilities for treatment for hepatitis C virus-induced cryoglobulinemic vasculitis and B-cell lymphoma].
    Ignatova TM; Mukhin NA
    Ter Arkh; 2012; 84(11):81-8. PubMed ID: 23252255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Essential mixed cryoglobulinemia type III with leukocytoclastic vasculitis: remission by rituximab.
    Baerlecken NT; Schmidt RE
    Clin Rheumatol; 2013 Mar; 32 Suppl 1():S19-20. PubMed ID: 20213127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryoglobulinemia vasculitis: an update.
    Terrier B; Cacoub P
    Curr Opin Rheumatol; 2013 Jan; 25(1):10-8. PubMed ID: 23196322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of systemic vasculitides].
    Guillevin L; Pagnoux C
    Rev Prat; 2008 Mar; 58(5):541-4. PubMed ID: 18524111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L11. Hepatitis C virus mixed cryoglobulinemia vasculitis: therapeutic options.
    Cacoub P; Terrier B; Saadoun D
    Presse Med; 2013 Apr; 42(4 Pt 2):523-7. PubMed ID: 23453499
    [No Abstract]   [Full Text] [Related]  

  • 14. Safety and efficacy of rituximab in nonviral cryoglobulinemia vasculitis: data from the French Autoimmunity and Rituximab registry.
    Terrier B; Launay D; Kaplanski G; Hot A; Larroche C; Cathébras P; Combe B; de Jaureguiberry JP; Meyer O; Schaeverbeke T; Somogyi A; Tricot L; Zénone T; Ravaud P; Gottenberg JE; Mariette X; Cacoub P
    Arthritis Care Res (Hoboken); 2010 Dec; 62(12):1787-95. PubMed ID: 20740617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Birmingham vasculitis activity score, disease extent index and complement factor C3c reflect disease activity best in hepatitis C virus-associated cryoglobulinemic vasculitis.
    Lamprecht P; Moosig F; Gause A; Herlyn K; Gross WL
    Clin Exp Rheumatol; 2000; 18(3):319-25. PubMed ID: 10895368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How HCV has changed the approach to mixed cryoglobulinemia.
    Della Rossa A; Baldini C; Tavoni A; Bombardieri S
    Clin Exp Rheumatol; 2009; 27(1 Suppl 52):S115-23. PubMed ID: 19646357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Vasculitis and liver disease].
    Spangenberg HC; Blum HE
    Praxis (Bern 1994); 2006 Oct; 95(40):1557-62. PubMed ID: 17048414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health-related quality of life in severe cryoglobulinaemic vasculitis and improvement after B-cell depleting therapy.
    Quartuccio L; Isola M; Masolini P; Scaini P; Zani R; Tavoni A; Pietrogrande M; Bombardieri S; De Vita S
    Clin Exp Rheumatol; 2013; 31(1 Suppl 75):S9-14. PubMed ID: 23044040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Life-threatening hepatitis C virus-associated polyarteritis nodosa successfully treated by rituximab.
    Néel A; Masseau A; Hervier B; Bossard C; Cacoub P; Pagnoux C; Hamidou MA
    J Clin Rheumatol; 2011 Dec; 17(8):439-41. PubMed ID: 22089995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyarteritis nodosa.
    Forbess L; Bannykh S
    Rheum Dis Clin North Am; 2015; 41(1):33-46, vii. PubMed ID: 25399938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.